My bookmarksSign up free

Commission Implementing Regulation (EU) 2016/2045 ANNEX

Commission Implementing Regulation (EU) 2016/2045 ANNEX

ANNEXSupplementary provisions

ANNEX In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘gamithromycin’ is replaced by the following: Pharmacologically active Substance Marker residue Animal Species MRLs Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification ‘Gamithromycin Gamithromycin All ruminants except bovine 50 μg/kg Muscle Not for use in animals producing milk for human consumption Anti-infectious agents/Antibiotics’ 50 μg/kg Fat 300 μg/kg Liver 200 μg/kg Kidney Bovine 20 μg/kg Fat 200 μg/kg Liver 100 μg/kg Kidney Porcine 100 μg/kg Muscle NO ENTRY 100 μg/kg Skin and fat in natural proportions 100 μg/kg Liver 300 μg/kg Kidney

Read the full instrument →

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04

CitationANNEX of Commission Implementing Regulation (EU) 2016/2045 (LawPlayer, data as of 2026-07-04)

© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.

What to look at next